Related Experiment Video
Updated: May 9, 2026
11:07
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
Published on: November 24, 2021
The development of the rotigotine transdermal patch: a historical perspective
1Division of Movement Disorders, Columbia University, 710 West 168th Street, New York, NY 10032, USA. cw345@mail.cumc.columbia.edu
Neurologic Clinics
|August 13, 2013
Summary
The rotigotine transdermal system provides continuous dopamine receptor agonist delivery for Parkinson's disease (PD). Preclinical and clinical studies confirm its effectiveness for treating early and advanced PD.
Area of Science:
- Neurology
- Pharmacology
- Dermatology
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder affecting motor function.
- Current treatments aim to manage dopamine deficiency.
- Continuous drug delivery systems offer potential therapeutic advantages.
Purpose of the Study:
- To review the development and efficacy of the rotigotine transdermal system.
- To examine rotigotine's pharmacological profile and pharmacokinetic properties.
- To assess the role of preclinical and clinical data in supporting rotigotine therapy.
Main Methods:
- Review of rotigotine's receptor binding profile.
- Analysis of steady-state pharmacokinetics and metabolism.
- Evaluation of preclinical animal models of PD.
- Assessment of proof-of-concept clinical studies in PD patients.
Main Results:
- Rotigotine is a dopamine receptor agonist with continuous 24-hour delivery via transdermal system.
- Preclinical studies demonstrated efficacy in animal models.
- Clinical studies confirmed proof-of-concept for rotigotine treatment in PD.
- The transdermal system ensures consistent drug delivery across the skin.
Conclusions:
- The rotigotine transdermal system is an effective continuous delivery method for Parkinson's disease.
- Established preclinical and clinical data support its use in early and advanced PD.
- This system forms the basis for ongoing clinical development and therapeutic application.
Related Concept Videos
01:18Transdermal Drug Delivery Systems
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:18Patch Clamp
Many fundamental cell functions such as muscle contraction and nerve transmission rely on the electrical signals produced by the movement of positively and negatively charged ions across the cell membrane. One competent method to record current flowing across the whole cell or single ion channel is the patch-clamp technique.
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
In this method, a glass micropipette containing electrolyte solution is tightly sealed against a small portion of the cell membrane. As a result, a patch of the cell...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...
01:26Oral Drug Delivery Systems: Continuous-Release Systems
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...